The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States
Open accessAbstract
In the United States, Lyme disease is caused by Borrelia burgdorferi and transmitted to humans by blacklegged ticks. Patients with an erythema migrans lesion and epidemiologic risk can receive a diagnosis without laboratory testing. For all other patients, laboratory testing is necessary to confirm the diagnosis, but proper interpretation depends on symptoms and timing of illness. The recommended laboratory test in the United States is 2-tiered serologic analysis consisting of an enzyme-linked immunoassay or immunofluorescence assay, followed by reflexive immunoblotting. Sensitivity of 2-tiered testing is low (30%-40%) during early infection while the antibody response is developing (window period). For disseminated Lyme disease, sensitivity is 70%-100%. Specificity is high (>95%) during all stages of disease. Use of other diagnostic tests for Lyme disease is limited. We review the rationale behind current US testing guidelines, appropriate use and interpretation of tests, and recent developments in Lyme disease diagnostics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liang, F. T., Steere, A. C., Marques, A. R., Johnson, B. J. B., Miller, J. N., & Philipp, M. T. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.12.3990-3996.1999 · Cited by 279 · cited 1×
“These Borrelia antigens are highly conserved and immunogenic among all Lyme borreliosis species and strains, and cause an early antibody response useful for diagnostic testing (18).”
Background
Cited by
Madison-Antenucci, S., Kramer, L. D., Gebhardt, L. L., & Kauffman, E. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00083-18 · Cited by 586
Lantos, P. M., Rumbaugh, J., Bockenstedt, L. K., Falck-Ytter, Y. T., Aguero-Rosenfeld, M. E., Auwaerter, P. G., Baldwin, K., Bannuru, R. R., Belani, K. K., Bowie, W. R., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1215 · Cited by 376
Lyme borreliosis–from tick bite to diagnosis and treatment
Stanek, G., & Strle, F. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux047 · Cited by 265
Diagnosis and Treatment of Lyme Carditis
Yeung, C., & Baranchuk, A. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.035 · Cited by 159
Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study
Webber, B. J., Burganowski, R. P., Colton, L., Escobar, J. D., Pathak, S. R., & Gambino-Shirley, K. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.02.020 · Cited by 57
Metadata
- Authors
- Moore, A., Nelson, C., Molins, C., Mead, P., & Schriefer, M.
- Venue
- Emerging Infectious Diseases
- Published
- 2016-07
- Volume
- 22
- Issue
- 7
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2425330162
- Cited by
- 186
- References
- 1
- FWCI
- 18.87
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States. https://app.cochat.ai/papers/10.3201/eid2207.151694
- The paper
- Moore, A., Nelson, C., Molins, C., Mead, P., & Schriefer, M. (2016). Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States. Emerging Infectious Diseases. https://doi.org/10.3201/eid2207.151694
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.